EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
    5.1.1.18 | Alzheimer Disease |
15285800 |
Induction of serine racemase expression and D-serine release from microglia by amyloid beta-peptide. |
causal interaction
diagnostic usage
ongoing research
unassigned |
4
4
1
0 |
| 5.1.1.18 | Alzheimer Disease |
18812225 |
Recombinant human serine racemase: enzymologic characterization and comparison with its mouse ortholog. |
causal interaction
therapeutic application
unassigned |
1
4
0 |
| 5.1.1.18 | Alzheimer Disease |
31212068 |
Neurotoxic astrocytes express the d-serine synthesizing enzyme, serine racemase, in Alzheimer's disease. |
unassigned |
0 |
| 5.1.1.18 | Amyotrophic Lateral Sclerosis |
22117694 |
Paradoxical roles of serine racemase and D-serine in the G93A mSOD1 mouse model of amyotrophic lateral sclerosis. |
unassigned |
0 |
| 5.1.1.18 | Ataxia Telangiectasia |
23018631 |
Individualized therapy for type 2 diabetes: clinical implications of pharmacogenetic data. |
causal interaction
unassigned |
1
0 |
| 5.1.1.18 | Brain Diseases |
29413527 |
The Role of Serine Racemase in the Pathophysiology of Brain Disorders. |
unassigned |
0 |
| 5.1.1.18 | Brain Ischemia |
15066209 |
Serine racemase expression in mouse cerebral cortex after permanent focal cerebral ischemia. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
2
1
3
1 |
| 5.1.1.18 | Brain Ischemia |
20107067 |
Serine racemase deletion protects against cerebral ischemia and excitotoxicity. |
therapeutic application
unassigned |
2
0 |
| 5.1.1.18 | Brain Ischemia |
27693471 |
Serine racemase inhibition induces nitric oxide-mediated neurovascular protection during cerebral ischemia. |
causal interaction
therapeutic application
unassigned |
2
1
0 |
| 5.1.1.18 | Choroidal Neovascularization |
28892569 |
Serine racemase deficiency attenuates choroidal neovascularization and reduces nitric oxide and VEGF levels by retinal pigment epithelial cells. |
causal interaction
unassigned |
3
0 |
